Know Cancer

or
forgot password

Environmental and Genetic Determinants of NPC


N/A
21 Years
N/A
Open (Enrolling)
Both
NPC

Thank you

Trial Information

Environmental and Genetic Determinants of NPC


Nasopharyngeal carcinoma (NPC) is one of the most common malignant tumors in southern China
and Southeast Asia. While infection with Epstein-Barr Virus (EBV) is believed to be
necessary for the development of NPC, non-viral environmental factors have also been
implicated in the carcinogenesis of NPC including consumption of salted fish and other
nitrosamine containing preserved foods, formaldehyde and wood dust exposure, cigarette
smoking, and betel nut chewing. In addition to environmental factors, it is widely accepted
that genetic susceptibility plays an important role in the pathogenesis of NPC.
Polymorphisms in genes involved in antigen presentation, nitrosamine metabolism and DNA
repair have been suggested to be associated with NPC risk, and various chromosomal regions
linked to NPC development have been reported. Two recently completed NPC GWAS have reported
that the strongest evidence for disease association is observed for SNPs located on the 3.6
Mb Major Histocompatibility Complex (MHC) region on chromosome 6p21 where human leukocyte
antigen (HLA) genes are located. These associations highlight the role of both environmental
exposures and genomic variation in the etiology of NPC. However, the specific role of EBV
on NPC pathogenesis is not completely understood and studies to date have had difficulty
pinpointing the specific genetic factors involved in NPC pathogenesis due to the complexity
of the MHC region and limited sample size of candidate gene studies.

DCEG investigators and their Taiwan colleagues have a longstanding history of studies to
elucidate the role of environmental and genetic factors associated with NPC. A case-control
study (375 cases; 327 controls) was conducted in the early 1990s and was followed by a large
multiplex family study that was completed in 2006 (358 families; 3,216 individuals).
Results from these studies have provided a substantial portion of the epidemiological
evidence regarding factors linked to NPC development to date.

At this time, we propose a new case-control study in Taiwan designed to 1) comprehensively
evaluate environmental risk factors for NPC; 2) systematically evaluate genetic risk factors
for NPC for which previous GWAS and candidate-gene studies have suggested an association;
and 3) explore gene-gene and gene-environment interactions for strong main effects
identified in our study. In total, up to 2000 cases and 2000 controls are expected to be
recruited from five participating hospitals in Northern Taiwan. Cases will consist of 550
incident cases ascertained retrospectively and 1350 incident cases ascertained
prospectively. Controls will be hospital based; they will be frequency matched (1:1) to
cases on age, gender and ethnicity, and will exclude individuals referred to the
participating hospitals due to conditions associated with known NPC risk factors.

This project is a collaborative effort between investigators in Taiwan and at the NCI.
Investigators in Taiwan will fund the field recruitment and data collection effort. Results
from this study have the potential to further clarify currently controversial environmental
risk factors as well as elucidate genetic factors of NPC.

Inclusion Criteria


- INCLUSION CRITERIA:

Eligibility criteria for cases:

- Incident diagnosis of NPC between 2010-2015

- Age greater than or equal to 21 years at NPC diagnosis

- Histologically confirmed

- Resident of northern Taiwan greater than or equal to 6 months

Eligibility criteria for controls:

- Resident of northern Taiwan greater than or equal to 6 months

- Matched to case based on age at diagnosis, gender, and ethnicity

EXCLUSION CRITERIA:

Exclusion criteria for controls:

- Clinic attendance due to conditions associated with EBV or smoking

Type of Study:

Observational

Study Design:

N/A

Principal Investigator

Allan Hildesheim, Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

National Cancer Institute (NCI)

Authority:

United States: Federal Government

Study ID:

999911040

NCT ID:

NCT01257100

Start Date:

November 2010

Completion Date:

Related Keywords:

  • NPC
  • NPC
  • Genetic
  • Environment
  • Nasopharyngeal Carcinoma

Name

Location